Effect of Instrument Assisted Soft Tissue Mobilization on Hand Post Surgical Scars in Primary Flexor Tendons Repair in Zone v

NCT ID: NCT07009197

Last Updated: 2025-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-05

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study will be conducted to investigate the effect of instrument assisted soft tissue mobilization on hand post surgical scars in primary flexor tendons repair in zone v

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The hand plays an important role in independent daily living and in communication with the environment. As the most mobile part of the upper extremity, the hand is actively used in everyday life and professional fields. The flexor tendons of the hand are critical for normal hand function. Injury to these tendons can result in absent finger and wrist flexion, and a subsequent loss of overall hand function. The surgical techniques used to repair these tendons have improved in the past few decades, as have the postoperative rehabilitation protocols. In spite of these advances, flexor tendon repairs continue to be plagued by postoperative scar formation, which limits tendon gliding and prevents a full functional recovery. Many different treatment methods can reduce the trauma and surgical scars. Manual scar treatment is one of these methods. Manual scar therapy to be effective requires applying physiological stimuli adequately to the phase of wound healing. Scar tissue therapy is a treatment for reducing pain and functional limitations, improving pliability, reducing hyper-pigmentation, pruritus, fascial adhesions, to reduce scar thickness and smooth surface area. Instrument assisted soft tissue mobilization (IASTM) is a soft-tissue treatment technique where an instrument is used to provide a mobilizing stimulus to positively affect scar tissue and myofascial adhesion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hand Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

instrumented assisted soft tissue mobilization and tradional therapy
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
opaque sealed envelope

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Instrument Assisted Soft Tissue Mobilization

Twenty-one patients will receive instrument-assisted soft tissue mobilization and traditional therapy three times a week for four weeks.

Group Type EXPERIMENTAL

Instrument Assisted Soft Tissue Mobilization

Intervention Type OTHER

the treatment will start by disinfect the instrument between patients to avoid transfer of infections. It is recommended to disinfect the instrument with intermediate-level disinfectants (e.g. isopropyl alcohol), then wash it with soap and water to remove any residuals of the chemical disinfectant off the instrument. If the tools contacts blood, bodily fluids, mucous membranes, or non-intact skin then disinfecting it with high-level disinfectant should be done .IASTM will be done at 30-60 degrees angle for 40-120 seconds+ radiational therapy

traditional therapy

Intervention Type OTHER

the patients will receive traditional therapy in the form of ultrasound, scar massage, and stretching exercises.

traditional therapy

Twenty-one patients will receive traditional therapy three times a week for four weeks.

Group Type ACTIVE_COMPARATOR

traditional therapy

Intervention Type OTHER

the patients will receive traditional therapy in the form of ultrasound, scar massage, and stretching exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Instrument Assisted Soft Tissue Mobilization

the treatment will start by disinfect the instrument between patients to avoid transfer of infections. It is recommended to disinfect the instrument with intermediate-level disinfectants (e.g. isopropyl alcohol), then wash it with soap and water to remove any residuals of the chemical disinfectant off the instrument. If the tools contacts blood, bodily fluids, mucous membranes, or non-intact skin then disinfecting it with high-level disinfectant should be done .IASTM will be done at 30-60 degrees angle for 40-120 seconds+ radiational therapy

Intervention Type OTHER

traditional therapy

the patients will receive traditional therapy in the form of ultrasound, scar massage, and stretching exercises.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both sex will be included in this research
* Hand scar in zone v
* Age varying from 20 to 40
* Hand scar formed post primary flexor tendons repair

Exclusion Criteria

* Vascular injuries requiring arterial repair
* Soft tissue loss
* Fractures
* Tendon in-juries of other zones
* Preexisting problems such as arthritis limiting joint motion
* unhealed wounds or age of scar under 6 weeks
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alzahraa labib abdalaziz

principle investigator : alzahraa labib abdalziz

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

alzahraa labib, master

Role: CONTACT

01010602832

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/005611

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.